+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Antidiabetics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Insulin and Insulin Analogs , GLP-1 Receptor Agonists , SGLT2 Inhibitors , DPP-4 Inhibitors , Biguanides , Alpha-Glucosidase Inhibitors, Sulfonylureas & Thiazolidinediones , Dual GLP-1), By Disease (Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus, Gestational Diabetes), By Route of Administration (Injectable Formulations, Oral Medications), By End-User (Hospital Pharmacies, Retail Pharmacies and Drugstores, Diabetes Clinics & Endocrinology Centers, Online) Companies, and Country Forecast, 2021 to 2034

Global Antidiabetics Market size is forecast to increase from $113.79 Billion in 2026 to $267.96 Billion in 2034 at a CAGR of 11.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005647
Pages: 230 Pages

Antidepressant Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Selective Serotonin Reuptake Inhibitors , Serotonin-Norepinephrine Reuptake Inhibitors , Tricyclic Antidepressants , Monoamine Oxidase Inhibitors , Serotonin Antagonist and Reuptake Inhibitors , Atypical Antidepressants), By Disease Indication (Major Depressive Disorder , Generalized Anxiety Disorder , Obsessive-Compulsive Disorder , Panic Disorder and Post-Traumatic Stress Disorder ), By Route of Administration (Oral , Injectable, Nasal Spray ), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Antidepressant Drugs Market size is forecast to increase from $18.69 Billion in 2026 to $24.23 Billion in 2034 at a CAGR of 3.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005646
Pages: 220 Pages

Anti-counterfeit Pharmaceuticals and Cosmetics Packaging Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Trace and Track Systems , Tamper-Evident Packaging, Overt Features , Covert Features , Forensic Markers), By Packaging Component (Labels and Tags, Security Inks and Coatings, Blister Packs and Pouches, Bottles and Closures, Cartons and Boxes), By End-Use Industry (Pharmaceuticals and Healthcare, Cosmetics and Personal Care) Companies, and Country Forecast, 2021 to 2034

Global Anti-counterfeit Pharmaceuticals and Cosmetics Packaging Market size is forecast to increase from $108.11 Billion in 2026 to $213.84 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005645
Pages: 213 Pages

Anticonvulsants Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Carboxamides, Benzodiazepines, Barbiturates, Hydantoins, Fatty Acid Derivatives , GABA Analogs, Triazines, Succinimides), By Route of Administration (Oral , Parenteral , Topical ), By Application (Epilepsy and Seizures, Neuropathic Pain, Bipolar Disorder , Migraine Prophylaxis, Fibromyalgia and Anxiety Disorders), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Anticonvulsants Market size is forecast to increase from $28.22 Billion in 2026 to $42.98 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005644
Pages: 211 Pages

Anticoccidial Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Ionophores, Synthetic/Chemical Derivative Anticoccidials, Combination Therapies, Biologics & Vaccines), By Animal Type (Poultry , Livestock , Companion Animals ), By Form (Dry , Liquid ), By Route of Administration (Oral , Injectable), By Distribution Channel (Veterinary Hospitals & Clinics, Feed Mills & Distributors, Retail & Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Anticoccidial Drugs Market size is forecast to increase from $222.22 Billion in 2026 to $318.45 Billion in 2034 at a CAGR of 4.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005643
Pages: 220 Pages

Anticoagulants Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Direct Oral Anticoagulants , Low Molecular Weight Heparin , Unfractionated Heparin , Vitamin K Antagonists ), By Route of Administration (Oral, Injectable ), By Indication (Atrial Fibrillation, Deep Vein Thrombosis , Pulmonary Embolism , Myocardial Infarction, Stroke Prevention), By End User (Hospitals & Clinics, Ambulatory Surgical Centers , Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Anticoagulants Market size is forecast to increase from $42.03 Billion in 2026 to $65.49 Billion in 2034 at a CAGR of 5.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005642
Pages: 229 Pages

Anticoagulant Reversal Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Specific Reversal Agents, Prothrombin Complex Concentrates , Phytonadione , Protamine Sulfate, Fresh Frozen Plasma ), By Anticoagulant Reversed (Direct Thrombin Inhibitor Reversal, Factor Xa Inhibitor Reversal, Vitamin K Antagonist Reversal, Heparin/Parenteral Anticoagulant Reversal), By Indication (Life-threatening Major Bleeding, Intracranial Hemorrhage, Gastrointestinal Bleeding, Emergency Surgery/Urgent Procedures), By End User (Hospitals, Ambulatory Surgical Centers , Emergency Medical Services) Companies, and Country Forecast, 2021 to 2034

Global Anticoagulant Reversal Drugs Market size is forecast to increase from $2.09 Billion in 2026 to $5.4 Billion in 2034 at a CAGR of 12.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005641
Pages: 230 Pages

Anti-CD20 Monoclonal Antibodies Market Size, Share and Growth Outlook, 2026: Analysis By Product (Rituximab & Biosimilars, Ocrelizumab, Ofatumumab, Obinutuzumab, Next-Generation Product Types), By Target Indication (B-Cell Malignancies / Oncology , Autoimmune & Neurological Disorders ), By Route of Administration (Intravenous , Subcutaneous ), By End-User (Hospitals & Inpatient Wards, Cancer Centers & Outpatient Infusion Clinics, Ambulatory Surgical & Care Centers, Neurology & Specialty Clinics), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Anti-CD20 Monoclonal Antibodies Market size is forecast to increase from $26.42 Billion in 2026 to $70.73 Billion in 2034 at a CAGR of 13.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005640
Pages: 223 Pages

Anti-Cancer Drug Market Size, Share and Growth Outlook, 2026: Analysis By Therapy (Targeted Therapy , Immunotherapy , Cytotoxic Chemotherapy , Hormonal Therapy), By Indication (Breast Cancer, Lung Cancer , Blood / Hematologic Cancers , Prostate Cancer, Gastrointestinal Cancers , Gynecologic Cancers ), By Route of Administration (Injectable / Parenteral , Oral), By End-User (Hospitals, Oncology Specialty Clinics, Ambulatory Care & Infusion Centers), By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Anti-Cancer Drug Market size is forecast to increase from $302.65 Billion in 2026 to $663.05 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005639
Pages: 213 Pages

Antibody Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Format (Monoclonal Antibodies , Multispecific Antibodies, Antibody-Drug Conjugates , Polyclonal Antibodies, Antibody Fragments), By Source Type (Human Antibodies, Humanized Antibodies, Chimeric Antibodies, Murine Antibodies), By Disease Area (Oncology, Autoimmune & Inflammatory Diseases, Neurology / Central Nervous System , Hematological Diseases, Infectious Diseases, Ophthalmology), By Route of Administration (Intravenous , Subcutaneous ), By End-User (Hospitals & Inpatient Clinics, Specialty & Outpatient Infusion Centers, Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Antibody Therapeutics Market size is forecast to increase from $323.53 Billion in 2026 to $916.44 Billion in 2034 at a CAGR of 13.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005638
Pages: 222 Pages